| Z03838 | |
|
|
|
| ¥61,625.00 | |
|
|
|
|
|
|
| Ask us a question | |
| Species | Cynomolgus | ||||
| Protein Construction |
|
||||
| Purity |
> 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC |
||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 32.73 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 55-70 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from a 0.22 μm filtered solution in PBS, pH 7.4. | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
| Target Background | CEACAM6 (carcinoembryonic antigen-related cell adhesion molecule 6), is encoded by the human CEACAM6 gene. It plays a probable role in both cell-cell signaling and cell adhesion, promoting tumor progression, invasion and metastasis. It is upregulated in pancreatic adenocarcinoma, breast cancer and non-small cell lung cancer. |
| Synonyms | CEACAM6; CD66c; CEAL; NCA; CEA |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
